Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Isotretinoin is highly effective in treating severe acne, rosacea, and gram-negative folliculitis.

Tinea capitis, a scalp fungal infection in children, is best treated with newer antifungal agents for shorter periods.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A Brittany spaniel's skin issues from cephalexin improved with treatment, showing drug-induced pemphigus foliaceus.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

New acne treatments show promise as alternatives to traditional therapies.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Local antibiotic therapy can effectively treat root canal infections.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

The antibacterial toner can effectively kill acne-causing bacteria by penetrating skin plugs.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Secukinumab effectively treated a difficult case of folliculitis decalvans.